Market Wizard
12.8K subscribers
63.8K photos
10 videos
1.16K files
21.3K links
FREE FINANCIAL EDUCATIONAL CHANNEL

Disclaimer : We are not SEBI Registered. Please consult your financial advisor before investing.

All the posts appearing in the channel are only for educational and informational purposes.

ALL RIGHTS RESERVED!!!
Download Telegram
*Good Morning*
• RBI Steps Up Loan Relief, Liquidity for India’s Virus Fight
o Central bank to provide $6.8b liquidity to key sectors
• Tata Steel Posts Bumper Profit on Price Rally, Demand Revival
• India Plans to Privatize IDBI Bank, Seek Strategic Investor
• Indian Delegation Self-Isolates at G-7 Meeting of Top Diplomats
• China Urges India to Provide Level Playing Field for Its Firms
• India’s Currency Market Roiled as Banks Protect Dollar Assets
o State-run banks are staying away from receiving dollars
• Saudi Arabia Cuts Oil Prices for Asia as India Battles Virus
• India to Boost Fuel Exports Through June on Better Margin: FGE
• India Oil Demand to Drop 670k B/D in May as Outlook Darkens: FGE
• SpiceJet, Dunzo Receive Approval for Drone Operations in India
• Global Funds Sell Net INR11.1B of India Stocks on Wednesday: NSE
o Domestic funds buy net 2.41b rupees of stocks
• Foreign Investors Sell Net INR17.4B of India Equities on May 4
• Foreigners Sell Net INR18.5B Indian Equity Derivatives Wednesday
• Oil Gains With U.S. Supply Drop Signaling Recovery
• EU Seeks India Support for Treaty on Plastic Pollution: Reuters
• Second covid wave may lead to slowdown in coming months: PHDCCI: PTI
• Three more Rafales head for India; to take IAF’s count to 21: PTI
• Adani Green (ADANIGR): 4Q net income 1.05b rupees Vs. 964.1m Y/y; Plans INR150B FY22 Capex
• Blue Dart (BDE): 4Q net income 890.8m rupees Vs. loss 237.9m Y/y; Revenue +33% to 9.66b
• Ceat (CEAT): 4Q net income 1.53b rupees vs. 518.8m y/y, beats est. 1.10b; Revenue +46% to 22.9b
• Cipla (CIPLA): Roche’s Covid Treatment Gets India Approval, Partner Cipla Says
• Tata Steel (TATA): 4Q net income 66.44b rupees vs. loss 14.80b y/y, misses est. 74.22b; Revenue +39% to 499.8b; To Raise India Capex Spending; to pay 25 rupees/shr as dividend
• Wipro Ltd. (WPRO): Says partners with Transcell Oncologics on vaccine safety AI

https://t.me/marketswizard

*Learning and earning group*

https://t.me/BooksMakeIndiaRead

*Knowledge Enhancement Group*
Stocks To Watch

IDBI Bank: Cabinet Committee on Economic Affairs has approved the strategic divestment of IDBI Bank, along with a transfer of management control. The extent of respective shareholding to be divested by government and Life Insurance Corporation to be decided at the time of structuring of transaction in consultation with RBI.

Tata Motors: Competition Commission of India has ordered a detailed probe against Tata Motors for alleged abuse of dominant position with respect to dealership agreements. The order has come on two complaints filed against Tata Motors, Tata Capital Financial Services and Tata Motors Finance. A clause in the dealership agreement allows Tata Motors to restrict, confine the territory of its dealers. Such a clause can create barriers to new entrants in the restricted market and can result in foreclosing of competition by hindering entry into the market, the competition regulator said.

Cipla: Roche has received emergency use authorisation in India for its investigational antibody cocktail (Casirivimab and Imdevimab) used in the treatment of Covid-19. The EUA will now enable Roche to import the globally manufactured product batches to India which will be marketed and distributed in India through a strategic partnership with Cipla.

Wipro: Has partnered with Transcell Oncologics to transform vaccine safety assessment using augmented intelligence. Transcell’s stem cell technology with the augmented intelligence capabilities of Wipro HOLMES® to improve the safety of global vaccine immunisation programs. Also, by applying AI to the vaccine development process, our solution can predict adverse neurovirulent impacts resulting from vaccinations, the company said.

Godrej Industries: Board has approved the Information memorandum for issuance of up to 7,500 listed, unsecured NCDs of the face value of Rs 10 lakh each, aggregating to Rs 750 crore on a private placement basis.

Maruti Suzuki: Total production in April stood at 1.59 lakh units. Total passenger vehicle production stood at 1.57 lakh units.

Force Motors: The company's total production in April stood at 1,042 units. It reported domestic sales of 1,094 units and exports of 187 units.

Indian Bank: Has declared Saravan Stores (Gold Palace) bad loan account as fraud and reported it to the RBI.

Bank of India: Has approved allotment of up to 42.11 crore shares at Rs 71.23 per share aggregating up to Rs 3,000 crore on a preferential basis to the Government of India.

Quess Corp: Has declared an interim dividend of Rs 7 per share for FY21. The record date for the same is May 13.

Nifty Earnings: Tata Consumer Products, Hero MotoCorp

Non-Nifty Earnings: Adani Power, Adani Transmission, Apcotex Industries, Bombay Burmah Trading Corp, Blue Star, Caplin Point Laboratories, Century Textiles & Industries, Coforge, CreditAccess Grameen, Foseco India, Hikal, ICRA, IIFL Finance, Procter & Gamble Health, Praj Industries, Raymond, Solara Active Pharma Sciences, Sundram Fasteners

https://t.me/marketswizard

*Learning and earning group*

https://t.me/BooksMakeIndiaRead

*Knowledge Enhancement Group*
#Results # THURSDAY

#NiftyWaali
Hero MotoCorp
Tata Consumer Products

#VaydaWaali
Coforge

#CashWaali
Adani Power
Adani Transmission
Blue Star
Century Textiles
ICRA
Praj Industries
Raymond
Sundram Fasteners
Solara Active
Apcotex Industries
CreditAccess, etc

https://t.me/marketswizard

*Learning and earning group*

https://t.me/BooksMakeIndiaRead

*Knowledge Enhancement Group*
*Brokerage Radar*

*MS on Tata Steel*
*OW, TP Rs 1000*
Key highlights:
a)in-line consol EBITDA despite better performance in India due to miss in Europe
b)robust cash flow & net debt reduction
c) restart of KPO2 capex
d) Dividend of Rs 25/sh, payout one of highest in last few yrs

*Macquarie on Tata Steel*
*O-P. TP Rs 1045*
Solid quarter; Constructive outlook
Solid deleveraging; announces growth capex
Key to track: earnings outlook particularly for EU given contract renegotiation, domestic demand outlook & expansion capex & timelines.

*CLSA on Tata Steel*
*Buy, TP Rs 1150*
4Q consol Ebitda 11% above est, debt reduction remains strong
Most biz performed better than est
Best-ever standalone profitability & 1Q likely to be even stronger
Europe largely in line; clarity awaited on several issues

*JPM on Tata Steel*
*OW,TP Rs 1250*
Large beat in 4Q, consol EBITDA at Rs141.8bn vs consensus of Rs128bn & underlying PAT at Rs80bn (reported PAT Rs71bn) vs consensus of Rs74bn
Given large price hikes seen in April & May, 1HFY22
should be very strong

*Jefferies on Tata Steel*
4Q adjusted EBITDA rose 68% QoQ (78% above 4QFY19) & 18% above JEFe
Rising steel prices drove sequentially higher EBITDA/t across biz
TATA generated free cash flow of Rs88bn in 4Q
Net Debt sell by Rs 90/sh

*Investec on Tata Steel*
Best is ahead… Preferred ferrous proxy
Operational beat across regions, strong CF generation (FCF Rs88/238b Q4/FY21) aids B/S deleveraging (debt reduction by Rs293b over FY21 to Rs753b)
Net gearing <1x
Dividends Rs25/sh

https://t.me/marketswizard

*Learning and earning group*

https://t.me/BooksMakeIndiaRead

*Knowledge Enhancement Group*